Sterile keratitis post collagen cross-linking (CXL) therapy for treatment of keratoconus
Corneal collagen cross-linking therapy is a relatively new treatment for progressing corneal ectasias such as keratoconus. Here the authors discuss the case of a 22-year-old male who underwent collagen cross-linking for treatment of progressive keratoconus, who then developed a serious post operative complication of a sterile keratitis.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication, with the work twelve (12) months after publication simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).